Preparing for Life and Academics for Young Childhood Cancer Survivors
Launched by NATIONWIDE CHILDREN'S HOSPITAL · Jan 6, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Preparing for Life and Academics for Young Childhood Cancer Survivors," is designed to test an online program called the PLAY program, which helps caregivers of young children who have survived cancer. The goal is to see if this program can improve parenting skills, reduce stress for caregivers, and help children get ready for school. Caregivers of children aged 3 to 6.5 years who have completed cancer treatment or are on maintenance therapy are invited to participate. To qualify, caregivers must be the child's legal guardian, live with the child more than half the time, speak English, and live within 150 miles of Nationwide Children's Hospital.
Participants in this study can expect to complete surveys and take part in a video interaction with their child at the beginning and end of the program. Over three months, caregivers will finish seven online modules and have up to eight one-hour video meetings with a trained coach. These sessions will provide support in preparing their child for school and managing family stress. After completing the program, caregivers will share their experiences in an interview, helping researchers learn how to improve the PLAY program in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Caregiver is the legal guardian of the child (e.g., mothers, fathers, grandparents, adoptive parents)
- • Caregiver lives with the child more than 50% of the time
- • Caregiver primary language is English
- • Caregiver lives within 150 miles of Nationwide Children's Hospital
- • Childhood cancer survivor received treatment for their cancer (e.g., chemotherapy, surgical resection, radiation therapy)
- • Childhood cancer survivor completed cancer treatment or on maintenance therapy only, without evidence of recurrent disease
- • Childhood cancer survivor is currently between the ages of 3 years old to 6 years old, but no older than 6.5 years old at study enrollment
- Exclusion Criteria:
- • Childhood cancer survivor has documented neurodevelopmental disorder prior to their cancer diagnosis (e.g., neurofibromatosis, tuberous sclerosis, Down's syndrome, autism)
- • Childhood cancer survivor did not receive any treatment (e.g., chemotherapy, surgical resection, radiation)
- • Childhood cancer survivors was treated for a benign tumor
About Nationwide Children's Hospital
Nationwide Children's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and trials. As a prominent sponsor, the hospital leverages its expertise in pediatric medicine to design and conduct rigorous clinical studies aimed at improving treatment outcomes for children. Committed to excellence in research and patient care, Nationwide Children's Hospital collaborates with a network of healthcare professionals and institutions to translate scientific discoveries into effective therapies, ensuring that the latest advancements in pediatric healthcare are accessible to young patients across the nation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported